ArticleOpen forum infectious diseases2026
Health-Related Quality of Life of Patients With Infective Endocarditis-A Cross-Sectional Study Based on Data From the DERIVE Cohort.
Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Infective endocarditis (IE) remains a severe condition with high morbidity and mortality despite advances in diagnostics and therapy. Health-related quality of life (HRQL) is an important outcome, yet high-quality data on HRQL in patients with IE are limited as most studies focused exclusively on surgically treated patients and did not assess HRQL at a defined time point. Methods: A cross-sectional analysis was performed on HRQL data from 259 patients diagnosed with IE between 11/2019 and 09/2023, derived from the prospective German DERIVE cohort. HRQL was evaluated 12 months after diagnosis using the EQ-5D-5L questionnaire and the EQ visual analog scale (EQ-VAS). Descriptive and nonparametric analyses were applied to compare HRQL across subgroups. Results: Of 338 one-year survivors, complete HRQL data were available for 259 patients (77%). The median EQ-5D index (interquartile range) was 0.91 (0.73-0.97), indicating persistent impairment compared with the general population. Female patients had lower HRQL than males (median EQ-5D index, 0.89 vs 0.91) and higher impairments in anxiety, pain, and usual activities. Younger patients (<55 years) experienced higher overall HRQL but more pain and anxiety, while patients older than 65 years reported greater physical limitations. No significant difference in EQ-5D index was observed between surgically and conservatively treated patients (0.91 vs 0.90); however, surgically treated patients reported higher levels of anxiety 1 year after diagnosis. Conclusions: Patients with IE experience persistent reductions in HRQL 1 year after diagnosis, affecting nearly all domains of daily life. The data highlight the importance of incorporating patient-reported outcomes into clinical management and long-term follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.